НовостиBenzingaRBC Capital Maintains Outperform on Versigent, Lowers Price Target to $52 RBC Capital Maintains Outperform on Versigent, Lowers Price Target to $52 Benzinga 2026.11.05 20:07 (GMT+0) Открыть на Benzinga Другие новости